Hong Kong Exchanges and Clearing Limited

FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation

Form Serial Number:

DA20200915E00020

1. Date of relevant event:

11/09/2020
(dd/mm/yyyy)

2. Date when director became aware of the relevant event/ interest in the shares (if later):

(dd/mm/yyyy)

3. Stock code:

01877

4. Name of listed corporation:

Shanghai Junshi Biosciences Co., Ltd. - H Shares

5. Class of shares:

H Shares

6. Number of issued shares in class:

182,746,500

7. Name of director (English) as printed on HKID Card/Passport:

(Surname)	TANG
(Other names)	Yi

10. Name of director (Chinese):

湯毅

11. Chinese Character Code as printed on HKID Card:

24. Details of relevant event:

Brief description of relevant event

Capacity in which shares were/are held

Number of shares bought/sold or involved

Currency of transaction

On Exchange

Off Exchange

Before relevant event

After relevant event

Highest price (per share)

Average price (per share)

Average consideration (per share)

Consideration code

Long position

1113	The number of shares in which you are interested has increased because: any other event (you must briefly describe the relevant event in the Supplementary Information box)

2201	Interest of corporation controlled by you

2,600

HKD

48.5000

Short position

25. Total shares in listed corporation immediately before the relevant event:

	Total number of shares	Percentage figure (%)
Long position	0	0.00

26. Total shares in listed corporation immediately after the relevant event:

	Total number of shares	Percentage figure (%)
Long position	2,600	0.00

27. Capacity in which interests disclosed in Box 26 are held:

Code describing capacity

Number of shares

2201	Interest of corporation controlled by you

Long position

2,600

28. Further information in derivative interests in listed corporation :

Derivatives code

Exercise period (dd/mm/yyyy)

Consideration - if derivatives granted by listed corporation

Number of shares

		Begins	Ends	Currency	Price for grant	Currency	Exercise price	Currency	Price on assignment

29. Further information in relation to interests of children under 18 and/or spouse:

Child/Spouse	Name of child/spouse	Number of shares

30. Further information in relation to interests of corporations controlled by Director:

Name of controlled corporation

Address and place of incorporation

Name of controlling person

% control

Direct interest (Y/N)

Number of shares

深圳前海源本股权投资基金管理有限公司

中国广东省深圳市前海深港合作区前湾一路鲤鱼门街1号前海深港合作管理局综合办公楼A栋201室 (中国)

Tang Yi

60.00

Long position

2,600

苏州本裕天源生物科技合伙企业(有限合伙)

中国江苏省苏州工业园区唯正路8号 (中国)

深圳前海源本股权投资基金管理有限公司

86.28

Long position

2,600

苏州瑞源盛本生物医药管理合伙企业(有限合伙)

中国江苏省苏州市吴江区松陵镇开发区云黎路北侧 (中国)

深圳前海源本股权投资基金管理有限公司

39.52

Long position

2,600

31. Further information in relation to interests held by Director jointly with another person:

Name of joint shareholder	Address	Number of shares

32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:

Names of Trust	Address	Status code	Number of shares

33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):

Names of other parties	Address	Number of shares

Total number of shares in which a director is interested under sections 317 and 318

34. Supplementary information:

Tang Yi's controlled corporations are parties to a concert party agreement dated 25 December 2017 (the "2017 Concert Party Agreement") and are deemed to be interested in the shares held by the other parties thereto. On 11 September 2020, a party to the 2017 Concert Party Agreement purchased 2600 H Shares. Tang Yi is deemed to be interested in the shares in which the controlled corporations are interested.

35. Log/Serial Number of the previous form:

36. Number of concert party document(s) under section 317 attached/uploaded:

Date of filing this Form 3A:

15/09/2020
(dd/mm/yyyy)